CLINICAL_TRIALS
trial_result
· 2025-07-30
Clinical Trial Update: Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan [Phase 4]
Summary
A Phase 4 trial in Pakistan evaluates adding Basaglar insulin (insulin glargine) to the treatment regimen for youth with Type 1 diabetes; the study has complete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Life for a Child Program, Diabetes Australia | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED